Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients

Status Completed

Clinical Trial Summary

The purpose of this study is to examine the effects of the sleep aid Lunesta (Eszopiclone), on older adults who reside in a nursing home and have poor sleep as determined by wrist actigraphy.

Clinical Trial Description

Older people living in nursing homes do not sleep very well for many reasons including pain, sleep disorders like sleep apnea (when someone briefly stops breathing during sleep) and night time urination, as well as the environmental disturbances caused by living in the nursing home, such as noise and disruptive care routines. Previous studies' attempts to improve sleep by modifying the nighttime nursing home environment have shown limited improvements in sleep.

This study will evaluate how well eszopiclone (Lunesta) works to improve sleep in nursing home residents with poor sleep. Eszopiclone is FDA approved and has been tested on older adults living in the community, but not on older adults living in nursing homes. We expect sleep to improve on the study drug, in comparison to the placebo. Based on adverse events reported in previous samples of older subjects, we expect the study drug to cause very few side effects.

We will evaluate how well eszopiclone works by measuring sleep at night and during the day. After consenting and final determination of eligibility, participants will complete a baseline phase to assess typical sleep, as well as daytime alertness and activity, thinking, memory and mood. Sleep at night and during the day will be objectively assessed with wrist actigraphs for all subjects. Approximately half will also receive polysomnographic studies to assess nighttime sleep. Subjects who sleep more than 75% of the time they are in bed will not continue in the study. Subjects will be randomized to one of two treatment groups—one will receive the active drug and then a placebo and the other will receive the placebo first and then the active drug. Following randomization, subjects will complete a brief run-in phase and then enter the treatment phase. Assessment of sleep and other measures will be repeated. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Poor Quality Sleep

Clinical Trial Details

NCT number	NCT00460993
Study type	Interventional
Source	Emory University
Contact
Status	Completed
Phase	Phase 4
Start date	June 2005
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04583033` - Sleep Well for Healthy Brain	N/A
Completed	`NCT06154616` - Efficacy of Different Types of Milk in Improving Sleep Quality in Subjects With Sleep Problems (Milca)	N/A
Completed	`NCT06154629` - Effect of a Botanical Ingredient in Healthy Subjects With Anxiety and Poor Sleep Quality	N/A
Enrolling by invitation	`NCT05838339` - Are You Daydreaming?	N/A
Terminated	`NCT01966315` - The Comparison of Dexmedetomidine and Midazolam for the Sleep in Intensive Care Unit
Completed	`NCT00253890` - Insomnia and Drug Relapse Risk	Phase 3
Completed	`NCT05478980` - The Effects of a Multi-ingredient Night-time Tea on Sleep Quality, Wellbeing and Markers of Immune Function	N/A
Withdrawn	`NCT01978340` - Eval EarlySense Bet Lowenstein Sleeplab	N/A
Completed	`NCT06107049` - the Effect of Probiotic on Sleep Quality Management	N/A
Not yet recruiting	`NCT03724474` - SMART Technology to Promote Heart Health in Midlife Adults	N/A
Completed	`NCT04779866` - Hypnosis for Sleep Quality in Caregivers of Individuals With Alzheimer's Disease	N/A
Not yet recruiting	`NCT04311372` - Sleep Wellness Program - University REST	N/A
Enrolling by invitation	`NCT05155787` - Neurofeedback Training (NFT) on Sleep Quality and Cognitive Function Performance Among HIV-infected Persons	N/A
Completed	`NCT02783027` - The SleepTrackTXT2 Randomized Trial With Air-medical Personnel	N/A
Completed	`NCT02825589` - BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients	N/A
Completed	`NCT04033601` - A Novel Strategy to Develop a Rapid Screen, Simple Subgrouping and Precise Intervention Model for Older Adults With Poor Sleep Quality	N/A
Completed	`NCT02042001` - Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects	Phase 4
Completed	`NCT01832155` - Yoga for Managing Knee Osteoarthritis in Older Women: a Feasibility Study	N/A
Completed	`NCT05609890` - Novel Formulation for Sleep Among People With Poor Sleep Quality	N/A
Completed	`NCT05215717` - Hypnosis for Sleep Quality for Individuals With Mild Cognitive Impairment	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.